Kanada - angielski - Health Canada

novopharm limited - desogestrel; ethinyl estradiol - tablet - 0.15mg; 0.03mg - desogestrel 0.15mg; ethinyl estradiol 0.03mg - contraceptives

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.25mg;  ;  ;  ;  ; digoxin 0.25mg - tablet - 0.25 mg - active: digoxin 0.25mg         excipient: lactose monohydrate magnesium stearate maize starch pregelatinised maize starch purified water rice starch active: digoxin 0.25mg excipient: lactose monohydrate magnesium stearate maize starch purified water rice starch starch, oxidised - cardiac failure:- lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation. supraventricular arrhythmias:- lanoxin is indicated in the management of certain supraventricular arrhythmias, particularly atrial flutter and fibrillation, where a major beneficial effect is reduction of the ventricular rate.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.0625mg;  ;  ;  ;  ; digoxin 0.0625mg - tablet - 0.0625 mg - active: digoxin 0.0625mg         excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone pregelatinised maize starch purified water rice starch active: digoxin 0.0625mg excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone purified water rice starch starch, oxidised - cardiac failure:- lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation. supraventricular arrhythmias:- lanoxin is indicated in the management of certain supraventricular arrhythmias, particularly atrial flutter and fibrillation, where a major beneficial effect is reduction of the ventricular rate.

Filipiny - angielski - FDA (Food And Drug Administration)

sandoz philippines corpration; distributor: sandoz philippines corpration - irbesartan - film-coated tablet - 150 mg

Filipiny - angielski - FDA (Food And Drug Administration)

sandoz philippines corpration; distributor: sandoz philippines corpration - irbesartan - film-coated tablet - 300mg

Malezja - angielski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga manufacturing berhad - ravidasvir hydrochloride -

Indie - angielski - Central Drugs Standard Control Organization

molekule - escitalopram - tab - 10mg - 10

Indie - angielski - Central Drugs Standard Control Organization

molekule - escitalopram - tab - 20mg - 10

Indie - angielski - Central Drugs Standard Control Organization

molekule - escitalopram - tab - 5mg - 10

Indie - angielski - Central Drugs Standard Control Organization

molekule - escitalopram,clonazepam - tab - 10,0.5;mg - 10